Tag: Praxis

Finance News

Praxis: A High-Risk, High-Reward Epilepsy Play Post Ulixacaltamide (Rating Upgrade)

03/03/2025
admin

Praxis: A High-Risk, High-Reward Epilepsy Play Post Ulixacaltamide (Rating Upgrade) #Praxis #HighRisk #HighReward #Epilepsy #Play #Post…

Stock

Praxis Precision Medicines to Present at Two February Investor Conferences

03/02/2025
admin

Praxis Precision Medicines to Present at Two February Investor Conferences#Praxis #Precision #Medicines #Present #February #Investor #Conferences

Stock

Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities By Investing.com

12/01/2025
admin

Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four…